Backed by a handful of prominent investors including the Gates Foundation, the startup is pursuing an approach it believes ...
The Promobilia Foundation is donating SEK 25 million to enable four research groups from Karolinska Institutet and Lund ...
The Life Science Community(TM), a leading B2B digital media platform serving the pharma, biotech, medtech, healthcare and research industries, today released its Xtalks 2025 Wrapped report, ...
Venture capitalist Bryan Johnson aims for human immortality by 2039, investing heavily in biotech and AI. He draws ...
The MM+M editorial team was heartened by the progress made treating Alzheimer’s disease, the case of KJ Muldoon and ...
Findings from two clinical trials suggest Novartis' Itvisma is safe and effective for SMA patients over two years old.
The clinical and biological features proposed here in conjunction with ML can improve the interpretation of CRC mechanisms and predict patient ...
Cui, J.X., Liu, K.H. and Liang, X.J. (2026) A Brief Discussion on the Theory and Application of Artificial Intelligence in ...
Morning Overview on MSN
New antibody stops one of the deadliest breast cancers
One of the most lethal forms of breast cancer has long shrugged off the best drugs in the oncologist’s arsenal, leaving ...
A major new UK study, led by The Christie NHS Foundation Trust and The University of Manchester, has been launched to help ...
JABSOM Cell and Molecular Biology researcher Dr. Jesse Owens has spent the better part of two decades chasing a vision that ...
Study finds CRISPR/Cas gene editing causes “chromatin fatigue” – another surprise mechanism by which it can produce unwanted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results